Completed
A Safety and Efficacy Study of Tavilermide (MIM-D3) Ophthalmic Solution for the Treatment of Dry Eye
NCT02634853
- Conditions
- Conjunctival Diseases, Conjunctivitis, Corneal Diseases, +6 more
- Locations
-
- MIM-727 Investigational Site Louisville, Kentucky, United States
- MIM-727 Investigational Site Nashville, Tennessee, United States